AGIO Company Profile and Key Details
Agios Pharmaceuticals, Inc.
AGIO Stock Price Chart
Stock Price Today
Agios Pharmaceuticals, Inc. (AGIO) stock surged +2.50%, trading at $34.06 on NASDAQ, up from the previous close of $33.23. The stock opened at $33.24, fluctuating between $33.13 and $34.47 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and AG-946 that is in Phase I clinical study for treating hemolytic anemias and other indications. Agios Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Cambridge, Massachusetts.
Company Information
| Employees | 383 |
| Beta | 0.75 |
| Sales or Revenue | $26.82M |
| 5Y Sales Change% | -0.707% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) stock price is $34.06 in the last trading session. During the trading session, AGIO stock reached the peak price of $34.47 while $33.13 was the lowest point it dropped to. The percentage change in AGIO stock occurred in the recent session was 2.5% while the dollar amount for the price change in AGIO stock was $0.83.
The NASDAQ listed AGIO is part of Biotechnology industry that operates in the broader Healthcare sector. Agios Pharmaceuticals, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Mr. Brian M. Goff M.B.A.
Chief Executive Officer & Director
Ms. Cecilia Jones
Chief Financial Officer
Holly Manning
Senior Director of Investor Relations
Dr. Clive Patience Ph.D.
Chief Technical Operations Officer
Mr. T. J. Washburn Jr.
Principal Accounting Officer
Ms. Richa Poddar
Chief Commercial Officer
Dr. Shin-San Su Ph.D.
Co-Founder & Member of Scientific Advisory Board
Dr. Tak Wah Mak D.Sc., FRSC, Ph.D.
Co-Founder & Member of Scientific Advisory Board
Dr. Lewis Clayton Cantley Ph.D.
Co-Founder & Member of Scientific Advisory Board
Dr. Sarah Gheuens M.D., Ph.D.
Chief Medical Officer and Head of R&D
Mr. James William Burns
Corporation Sec. & Chief Legal Officer
Dr. Craig B. Thompson M.D.
Co-Founder & Chairman of Scientific Advisory Board
AGIO's closing price is 60.81% higher than its 52-week low of $21.18 where as its distance from 52-week high of $62.58 is -45.57%.
Number of AGIO employees currently stands at 383.
Official Website of AGIO is: https://www.agios.com
AGIO could be contacted at phone 617 649 8600 and can also be accessed through its website. AGIO operates from 88 Sidney Street, Cambridge, MA 02139-4169, United States.
AGIO stock volume for the day was 605.12K shares. The average number of AGIO shares traded daily for last 3 months was 890.42K.
The market value of AGIO currently stands at $1.94B with its latest stock price at $34.06 and 57.03M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com